MYT1L Syndrome Care
There is currently no specific treatment for this syndrome.
Multidisciplinary support AND COORDINATION should be put in place as early as possible.
⚠ Point of vigilance
Several impacts described on this page may lead to the prescription of medication (behavioral disorders, anxiety, epilepsy, sleep, ADHD…). In individuals with MYT1L syndrome, these treatments may cause unusual, atypical, or even paradoxical reactions.
An essential insight for both families and healthcare professionals.
(👉 Read the full point of vigilance— click on the underlined text for direct access)
A stance of reasoned optimism
The PNDS issued in January 2026 highlights an essential message for all concerned persons and their caregivers:
"It is essential to adopt an open and non-restrictive clinical stance: the capacities and learning potential of these patients should not be assumed to be limited a priori. A professional attitude grounded in reasoned optimism and the exploration of ambitious intervention paths fosters sometimes unexpected acquisitions and supports long-term development."
— PNDS MYT1L Syndrome — Synthesis for the general practitioner, HAS, January 2026
VIGILANCE POINT — TREATMENTS Interactive — click to select language
MYT1L Support
There is NO SPECIFIC TREATMENT for this syndrome today.
However
-
Treatment may be initiated based on the clinical assessment made by the physician in relation to certain repercussions of the syndrome.
-
Strict frameworks may be imposed regarding diet, the practice of adapted, sustained and regular sporting activity.
!! MULTIDISCIPLINARY SUPPORT must be put in place AS SOON AS POSSIBLE.
RESOURCES
ORPHA CODE
647799
-
Orphanet code to be filled in or consulted if you are a physician, health care or social welfare professional...
-
Orphanet code to be indicated if you are a caregiver or patient
SUMMARY AND DESCRIPTION AVAILABLE IN ENGLISH AND FRENCH
